Compelling preclinical data in models of both GBA1-PD and idiopathic PD, demonstrating a disease-modifying effect after administration of GT-02287, suggest that GT-02287 may have the potential to slow ...
News Medical on MSN10d
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as keynote speakers at therapeutic oligonucleotides 2025ELRIG, a not-for-profit, volunteer-led organization for the drug discovery community, today announced the keynote speakers for Therapeutic Oligonucleotides 2025 taking place at the AstraZeneca R&D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback